✦ LIBER ✦

Tumor necrosis factor alpha (TNF-α) and estrogen hormone in osteoarthritic female patients

✍ Scribed by Pradeep Sharma; Neelima Singh; Vinod Singh; Sanjeev Singh; Harsh vardhan Singh; Sameer Gupta

Publisher: Association of Clinical Biochemistry of India
Year: 2006
Tongue: English
Weight: 51 KB
Volume: 21
Category: Article
ISSN: 0970-1915
DOI: 10.1007/bf02913099

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor necrosis factor alpha (TNF-α) gene

Tumor necrosis factor alpha (TNF-α) gene polymorphism in alopecia areata

✍ Gillian M. P. Galbraith; Janardan P. Pandey 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 358 KB

Tumor necrosis factor alpha (TNF-α) and

Tumor necrosis factor alpha (TNF-α) and sepsis: Evidence for a role in host defense

✍ O. Rigato; S. Ujvari; A. Castelo; R. Salomão 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 627 KB

Polymorphisms of tumor necrosis factor (

Polymorphisms of tumor necrosis factor (TNF) α and β genes in Korean patients with psoriasis

✍ Tai-Gyu Kim; Chul-Woo Pyo; Sung-Suk Hur; Yang-Kyum Kim; Ha-Young Hwang; Jai-Il Y 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 176 KB

The Development of New Isoxazolone Based

The Development of New Isoxazolone Based Inhibitors of Tumor Necrosis Factor-Alpha (TNF-α) Production.

✍ Michael P. Clark; et al. et al. 📂 Article 📅 2005 🏛 John Wiley and Sons ⚖ 32 KB 👁 1 views

Tumor necrosis factor alpha (TNFα) in hu

Tumor necrosis factor alpha (TNFα) in human skin: a comparison of different antibodies for immunohistochemistry

✍ N. van der Laan; L. F. M. H de Leij; Wim Buurman; Wim Timens; H. J. ten Duis 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 262 KB

Liver diseases associated with anti-tumo

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

✍ Carla S. Coffin; Hughie F. Fraser; Remo Panaccione; Subrata Ghosh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

The conventional treatment of inflammatory bowel disease (IBD) has focused on nonspecifically targeting mucosal inflammation. In the last decade, with the advent of novel biological agents that directly inhibit proinflammatory cytokines, such as tumor necrosis factor alpha (TNF-a), rapid progress ha